November 30, 2017
C. Nwokolo, O. B. Mokwelu, Uche Eva Eneasator
Test anxiety constitutes a serious academic impediment to lots of students in schools. This study investigated the Effects of Meditation technique on test anxiety among secondary school students in Anambra State, Nigeria. Two research questions guided the study and two null hypotheses were tested at 0.05 level of significance. Quasi-experimental research was adopted in carrying out the study. A...
Building Healthy Academic Communities Journal
November 27, 2017
John E. Lothes II, Kirk Mochrie
Background: Many studies have shown the positive effects of extended mindfulness interventions on anxiety reduction in several different populations; however, few have yet to examine the effects of mindfulness interventions on test anxiety in a college student population.Aim: This study assesses the effects of overall test anxiety reduction through the use of Dialectical Behavior Therapy's...
Trends in Psychiatry and Psychotherapy
November 13, 2017
Michele F. Rodrigues, Antonio E Nardi, Michelle Levitan
Abstract Introduction The objective of this study was to conduct a review of the literature covering the use of different mindfulness-based therapy approaches in treatment of mood and anxiety disorders, including mindfulness skills and mindfulness linked to emotional regulation and fear of negative appraisal. Methods A review was conducted of literature identified by searching the scientific...
Trends in Psychiatry and Psychotherapy
November 11, 2017
Lysa Remy, Juliana Nichterwitz Scherer, Luciano Santos Pinto Guimarães et al.
12 citations
Abstract Background This study examined drug use patterns and psychiatric symptoms of anxiety and depression among young Brazilian sexual minority ecstasy and LSD users and compared findings with those reported for their heterosexual peers. Method This cross-sectional study employed targeted sampling and ethnographic mapping approaches via face-to-face interviews conducted at bars and...
Scientific Reports
November 3, 2017
Sagnik Bhattacharyya, Alice Egerton, Euitae Kim et al.
Use of Cannabis, the most widely used illicit drug worldwide, is associated with acute anxiety, and anxiety disorders following regular use. The precise neural and receptor basis of these effects have not been tested in man. Employing a combination of functional MRI (fMRI) and positron emission tomography (PET), we investigated whether the effects of delta-9-tetrahydrocannabinol (delta-9-THC),...
Journal of Consulting and Clinical Psychology
November 1, 2017
Corey Roos, Sarah Bowen, Katie Witkiewitz
Objective: Few studies have evaluated moderators of mindfulness-based relapse prevention (MBRP) for substance use disorders (SUDs). We tested whether baseline patterns of scores for SUD symptom severity and depression and anxiety symptoms moderated the efficacy of MBRP. Method: We used a latent class moderation approach with data from a randomized trial of MBRP compared to cognitive–behavioral...
Journal of Psychopharmacology
October 2017
Paul Glue, Natalie J. Medlicott, Sarah Harland et al.
The N-methyl-D-aspartate receptor antagonist ketamine has rapid onset activity in treatment-resistant depression, post-traumatic stress disorder and obsessive compulsive disorder. Due to similarities in brain network activity in depression and anxiety disorders, we hypothesized that ketamine might also be active in other refractory anxiety disorders. We evaluated the efficacy and safety of...
Scandinavian Journal of Pain
October 1, 2017
Katherine B. Curtin, Deborah Norris
Abstract Background and purpose The Fear-Avoidance Model of Chronic Pain proposed by Vlaeyen and Linton states individuals enter a cycle of chronic pain due to predisposing psychological factors, such as negative affectivity, negative appraisal or anxiety sensitivity. They do not, however, address the closely related concept of anxious rumination. Although Vlaeyen and Linton suggest...
Behavioural Pharmacology
October 1, 2017
Alexandre Seillier, Andrea Giuffrida
Social withdrawal should not be considered a direct measure of the negative symptoms of schizophrenia as it may result not only from asociality (primary negative symptom) but also from other altered processes such as anxiety. To understand the contribution of these two factors to social deficit, we investigated whether the social withdrawal observed in the subchronic phencyclidine (PCP) rat...
Journal of Psychopharmacology
October 1, 2017
Cameron Castle, Andrew Gray, Shona Neehoff et al.
20 citations
Patients receiving ketamine for refractory depression and anxiety report dissociative symptoms in the first 60 min post-dose. The most commonly used instrument to assess this is the Clinician-Administered Dissociative States Scale (CADSS), developed based on the assessment of patients with dissociative symptoms. Its psychometric properties for ketamine-induced dissociation have not been...